The ACA has had a significant impact on uninsurance rates for racial and ethnic minorities, according to a new study by the Urban Institute.
The Affordable Care Act (ACA) has significantly reduced uninsurance rates for racial and ethnic groups, according to a new study by the Urban Institute, a non-profit policy research organization.
The study also found that the uninsurance gap between whites and all other minority groups except blacks has narrowed, attributable in part to Medicaid expansion. The uninsurance gap between whites and blacks has not narrowed because a disproportionately large number of blacks live in states that have not expanded Medicaid, according to the study.
The study found that a small group of states account for the majority of gains for certain ethnic groups.
Uninsured rate without the ACA:
Uninsured rate with 27 states and the District of Columbia expanding Medicaid:
Uninsured rate If all states expanded Medicaid:
The study’s authors - Lisa Clemans-Cope, Matthew Buettgens, and Hannah Recht, looked at U.S. Census’ American Community Survey data from 2009, 2010 and 2011 and applied it to a microsimulation model.
Results exclude undocumented immigrants because they’re prohibited from enrolling in Medicaid or purchasing coverage through the federal-facilitated marketplace or state exchanges. That group, says the study, makes up an estimated one-quarter of all remaining uninsured residents in the U.S. if no further states beyond the current number (27 plus the District of Columbia) expand Medicaid.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More